Blocking PLA1A enzyme may enhance chemoimmunotherapy by reducing immunosuppressive macrophages

◇ RESEARCH

Single-cell RNA sequencing of paired samples before and after neoadjuvant chemotherapy revealed that non-responders had increased M2-like macrophage infiltration linked to elevated PLA1A. (Cancer Res)